Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy
1997

Effects of Tamoxifen on TGF-beta in Breast Cancer

publication Evidence: moderate

Author Information

Author(s): J MacCallum, WR Miller

Primary Institution: ICRF Medical Oncology Unit, Western General Hospital

Hypothesis

What is the effect of tamoxifen on TGF-beta expression in breast cancers?

Conclusion

Tamoxifen treatment is associated with increased TGF-beta2 expression in responding tumors, but the effects on TGF-beta1 are variable.

Supporting Evidence

  • Tamoxifen treatment was associated with higher TGF-beta2 expression in responding tumors.
  • The effects of tamoxifen on TGF-beta1 expression were variable and not statistically significant.
  • Sequential samples allowed for accurate assessment of tumor response to tamoxifen.

Takeaway

This study looked at how a cancer treatment called tamoxifen affects certain proteins in breast cancer. It found that tamoxifen can increase one type of protein but has mixed effects on another.

Methodology

The study involved assessing sequential tumor samples from patients undergoing tamoxifen therapy to evaluate changes in TGF-beta expression.

Potential Biases

Potential biases may arise from inherent variations in methodology and tumor heterogeneity.

Limitations

The study is limited to a defined group of patients and does not explore the role of TGF-beta in different stages of disease.

Participant Demographics

Patients undergoing tamoxifen therapy for breast cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication